6-((2-(1,4,8,11-tetraazacyclotetradecan-1-yl)ethyl)amino)-2-dodecyl-1H-benzo[de]isoquinoline-1,3(2H)-dione | 1207670-50-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: 6-((2-(1,4,8,11-tetraazacyclotetradecan-1-yl)ethyl)amino)-2-dodecyl-1H-benzo[de]isoquinoline-1,3(2H)-dione
• 英文别名: 2-Dodecyl-6-[2-(1,4,8,11-tetrazacyclotetradec-1-yl)ethylamino]benzo[de]isoquinoline-1,3-dione；2-dodecyl-6-[2-(1,4,8,11-tetrazacyclotetradec-1-yl)ethylamino]benzo[de]isoquinoline-1,3-dione
• CAS: 1207670-50-5
• 化学式: C₃₆H₅₈N₆O₂
• 分子量: 606.896
• InChiKey: FVIKOIVOIFAZRT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7
• 重原子数：
  44
• 可旋转键数：
  15
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  88.7
• 氢给体数：
  4
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  6-((2-(1,4,8,11-tetraazacyclotetradecan-1-yl)ethyl)amino)-2-dodecyl-1H-benzo[de]isoquinoline-1,3(2H)-dione 、 nickel(II) perchlorate 以 甲醇 为溶剂， 生成 6-((2-(1,4,8,11-tetraazacyclotetradecan-1-yl)ethyl)amino)-2-dodecyl-1H-benzo[de]isoquinoline-1,3(2H)-dione-Ni(II)(ClO₄)₂
  参考文献：
  名称：

  Novel metal complexes of naphthalimide–cyclam conjugates as potential multi-target receptor tyrosine kinase (RTK) inhibitors: Synthesis and biological evaluation

  摘要：

  A novel series of metal complexes of naphthalimide-cyclam conjugates were synthesized and their in vitro antitumor activities were evaluated. The newly-synthesized compounds showed huge diversity of antiproliferative potency due to variety of metal ions and length of alkyl chains, among which the Zn(II) and Cr(III) complexes exhibited comparable antiproliferative activities with amonafide via multiple tyrosine kinase inhibition. Further research revealed that the representative compound 8a displayed broad-spectrum antiproliferative activity against 15 cancer cell lines with average IC50 value 10.18 +/- 3.25 mu M, and effective antiangiogenic activity on human microvascular endothelial cells (HMEC-1). In brief, metal complexes of naphthalimide-cyclam conjugates were firstly designed and synthesized as multi-target tyrosine kinase inhibitors and proved of their antitumor capacities. (C) 2014 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2014.07.068
• 作为产物：
  描述：

  6-bromo-2-dodecyl-1H-benzo[de]isoquinoline-1,3(2H)-dione 在 四丁基溴化铵 、 三苯基膦 、 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 氯仿 、 乙二醇甲醚 为溶剂， 反应 84.0h， 生成 6-((2-(1,4,8,11-tetraazacyclotetradecan-1-yl)ethyl)amino)-2-dodecyl-1H-benzo[de]isoquinoline-1,3(2H)-dione
  参考文献：
  名称：

  Novel metal complexes of naphthalimide–cyclam conjugates as potential multi-target receptor tyrosine kinase (RTK) inhibitors: Synthesis and biological evaluation

  摘要：

  A novel series of metal complexes of naphthalimide-cyclam conjugates were synthesized and their in vitro antitumor activities were evaluated. The newly-synthesized compounds showed huge diversity of antiproliferative potency due to variety of metal ions and length of alkyl chains, among which the Zn(II) and Cr(III) complexes exhibited comparable antiproliferative activities with amonafide via multiple tyrosine kinase inhibition. Further research revealed that the representative compound 8a displayed broad-spectrum antiproliferative activity against 15 cancer cell lines with average IC50 value 10.18 +/- 3.25 mu M, and effective antiangiogenic activity on human microvascular endothelial cells (HMEC-1). In brief, metal complexes of naphthalimide-cyclam conjugates were firstly designed and synthesized as multi-target tyrosine kinase inhibitors and proved of their antitumor capacities. (C) 2014 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2014.07.068

文献信息

• Antiproliferative and apoptosis-inducing activities of novel naphthalimide–cyclam conjugates through dual topoisomerase (topo) I/II inhibition
  作者：Shaoying Tan、Deheng Sun、Jiankun Lyu、Xiao Sun、Fangshu Wu、Qiang Li、Yiqi Yang、Jianxu Liu、Xin Wang、Zhuo Chen、Honglin Li、Xuhong Qian、Yufang Xu

  DOI：10.1016/j.bmc.2015.07.011

  日期：2015.9

  A novel series of naphthalimide-cyclam conjugates were designed and synthesized. Among them, compounds 4c, 4d, 8c and 8d which bearing long lipophilic alkyl chains, displayed comparable or more potent cytotoxic activities against human tumor cell lines than amonafide. Furthermore, the four compounds were proved to possess strong inhibition against both topoisomerase I and II. The representative compound 8c exhibited moderate DNA intercalation activity. Molecular modeling studies identified the possible interaction of compound 8c with the molecular target by forming topoisomerase/DNA/drug ternary complex. Finally, derivatives with long lipophilic alkyl chains could efficiently induce apoptosis. (C) 2015 Published by Elsevier Ltd.
• Novel metal complexes of naphthalimide–cyclam conjugates as potential multi-target receptor tyrosine kinase (RTK) inhibitors: Synthesis and biological evaluation
  作者：Shaoying Tan、Kun Han、Qiang Li、Linjiang Tong、Yiqi Yang、Zhuo Chen、Hua Xie、Jian Ding、Xuhong Qian、Yufang Xu

  DOI：10.1016/j.ejmech.2014.07.068

  日期：2014.10

  A novel series of metal complexes of naphthalimide-cyclam conjugates were synthesized and their in vitro antitumor activities were evaluated. The newly-synthesized compounds showed huge diversity of antiproliferative potency due to variety of metal ions and length of alkyl chains, among which the Zn(II) and Cr(III) complexes exhibited comparable antiproliferative activities with amonafide via multiple tyrosine kinase inhibition. Further research revealed that the representative compound 8a displayed broad-spectrum antiproliferative activity against 15 cancer cell lines with average IC50 value 10.18 +/- 3.25 mu M, and effective antiangiogenic activity on human microvascular endothelial cells (HMEC-1). In brief, metal complexes of naphthalimide-cyclam conjugates were firstly designed and synthesized as multi-target tyrosine kinase inhibitors and proved of their antitumor capacities. (C) 2014 Elsevier Masson SAS. All rights reserved.